Home > Healthcare > Medical Devices > Surgical Devices > Urinary Incontinence Treatment Devices Market

Urinary Incontinence Treatment Devices Market Share

Report ID: GMI8190
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Urinary Incontinence Treatment Devices Market Share

The urinary incontinence treatment devices industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for urinary incontinence treatment devices manufacturers. Some of the key industry players including Becton, Dickinson and Company, Boston Scientific Corporation, B Braun Melsungen AG, Caldera Medical Inc., and Medtronic plc among others have a substantial presence in the market.

Urinary Incontinence Treatment Devices Market Companies

Some of the eminent market participants operating in the urinary incontinence treatment devices industry include:

Becton, Dickinson and Company
Boston Scientific Corporation
B Braun Melsungen AG
Caldera Medical Inc.
Coloplast A/S
ConvaTec Group plc
Hollister Incorporated
Medtronic plc
PROMEDON GmbH
Teleflex Incorporated
Zephyr Surgical Implants

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market valuation of the urinary incontinence treatment devices was exceeded USD 3.1 billion in 2023 and is expected to reach around USD 6.5 billion by 2032, owing to the increasing prevalence of urinary incontinence (UI), growing incidence of prostate cancer, coupled with rise in target population base for urethral disorders.

The urethral slings segment was valued at over USD 1.5 billion in 2023 and will grow significantly through 2032 attributed to the rising demand for minimally invasive procedures globally.

North America urinary incontinence treatment devices industry accounted for USD 1 billion in 2023 and is predicted to witness substantial growth through 2032, owing to the awareness initiatives encouraging more people to seek medical attention.

Becton, Dickinson and Company, Boston Scientific Corporation, B Braun Melsungen AG, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Hollister Incorporated, Medtronic plc, PROMEDON GmbH, Teleflex Incorporated, and Zephyr Surgical Implants.